597
Views
28
CrossRef citations to date
0
Altmetric
RADIATION SENSITIVITY AND DNA METHYLATION

γ-radiation induces cellular sensitivity and aberrant methylation in human tumor cell lines

, , , , , & show all
Pages 1086-1096 | Received 29 Dec 2010, Accepted 08 Jul 2011, Published online: 07 Sep 2011

References

  • Ai L, Vo QN, Zuo C, Li L, Ling W, Suen JY, Hanna E, Brown KD, Fan CY. 2004. Ataxia-telangiectasia-mutated (ATM) gene in head and neck squamous cell carcinoma: Promoter hypermethylation with clinical correlation in 100 cases. Cancer Epidemiology Biomarkers and Prevention 13:150–156.
  • Armando AM, Katarzyna W, Yolanda AC, Silvio Z, Gertrud L, Kazimierz W. 2008. High-performance liquid chromatography determination of 5-methyl-2′-deoxycytidine, 2′-deoxycytidine and other deoxynucleosides and nucleosides in DNA digests. Analytical Biochemistry 374:378–385.
  • Baylin SB. 2005. DNA methylation and gene silencing in cancer. Nature Clinical Practice Oncology 2:S4–11.
  • Belka C, Budach W, Bamberg M. 2001. Radiation induced CNS toxicity – molecular and cellular mechanisms. British Journal of Cancer 85:1233–1239.
  • Biade S, Stobbe CC, Boyd JT, Chapman JD. 2001. Chemical agents that promote chromatin compaction radiosensitize tumor cells. International Journal of Radiation Biology 77:1033–1042.
  • Christa BK, Uwe H, Yelizabeta N, Jens K, Gerda H. 2000. Fluorometric analysis of DNA unwinding (FADU) as a method for detecting repair-induced DNA strand breaks in UV-irradiated mammalian cells. Photochemistry and Photobiology 72:477–484.
  • Costello JF, Berger MS, Huang HS, Cavenee WK. 1996.Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Research 56:2405–2410.
  • Das PM, Singal R. 2004. DNA methylation and cancer. Journal of Clinical Oncology 2:4632–4642.
  • Ehrlich M. 2002. DNA methylation in cancer: too much, but also too little. Oncogene 21:5400–5413.
  • Emily AV, Carolyn JB, Wan LL. 2008. Epigenetics of cancer progression. Pharmacogenomics 9:215–234.
  • Friedberg EC, Walker GC, Siede W. 1995. DNA repair and mutagenesis. Washington DC: ASM Press.
  • Furumai R, Komatsu Y, Nishino N, Khochbin S, Yoshida, Horinouchi S. 2001. Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin. Proceedings of the National Academy of Sciences of the USA 98:87–92.
  • Goldberg C, Lenhert BE. 2002. Radiation induced effects in unirradiated cells: A review and implication in cancer. International Journal of Oncology 21:337–349.
  • Gonzalgo ML, Jones PA. 1997. Mutagenic and epigenetic effects of DNA methylation. Mutation Research 386:107–118.
  • Goodhead DT. 1994. Initial events in the cellular effects of ionizing radiations: Clustered damage in DNA. International Journal of Radiation Biology 65:7–17.
  • Hall EJ. 1994. Radiobiology for the radiologist. 4th. Philadelphia: JB Lippincott Company.
  • Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G. 1996. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Molecular and Cellular Biology 16:859–867.
  • Iliakis G, Wang Y, Guan J, Wang H. 2003. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 22:5834–5847.
  • In AK, Jin HS, Il HK, Jin HK, Jae SK, Hong GW, Eui KC, Sung WH, Charn IP, Gary DK. 2006. Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: Class differences and the potential influence of p53. Clinical Cancer Research 12:940–949.
  • Jaenisch R, Bird A. 2003. Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nature Genetics 33:245–254.
  • Joseph J, Wajapeyee N, Somasundaram K. 2005. Role of p53 status in chemosensitivity determination of cancer cells against histone deacetylase inhibitor sodium butyrate. International Journal of Cancer 115:11–18.
  • Kalinich JF, Caravans GN, Snyder SL. 1989. The effect of gamma radiation on DNA methylation. Radiation Research 117:185–197.
  • Kim JH, Shin JH, Kim IH. 2004. Susceptibility radiosensitization of human glioblastoma cells to trichostatin-A, a histone deacetylase inhibitor. International Journal of Radiation Oncology Biology and Physics 62:1348–1354.
  • Kossenko MM, Degteva MO, Vyushkova OV, Preston DL, Mabuchi K, Kozheurov VP. 1997. Issues in the comparison of risk estimates for the population in the Techa River and atomic bomb survivors. Radiation Research 148:154–163.
  • Koturbash I, Pogribny I, Kovalchuk O. 2005. Stable loss of global DNA methylation in the radiation target tissue – a possible mechanism contributing to radiation carcinogenesis? Biochemical and Biophysical Research Communications 337:526–533.
  • Kovalchuk O, Hendricks CA, Cassie S, Engelward AJ, Engelward BP. 2004. In vivo recombination after chronic damage exposure falls to below spontaneous levels in ‘recombomice’. Molecular Cancer Research 2:567–573.
  • Laird PW, Jaenisch R. 1996. The role of DNA methylation in cancer genetic and epigenetics. Annual Review of Genetics 30:441–464.
  • Larsen F, Gundersen G, Lopez R, Prydz H. 1992. CpG islands as gene markers in the human genome. Genomics 13:1095–1107.
  • Little JB. 1998. Radiation induced genomic instability. International Journal of Radiation Biology 74:663–671.
  • Little JB. 2000. Derivative of low dose extrapolation factors from analysis of curvature in the cancer incidence dose response in Japanese atomic bomb survivors. International Journal of Radiation Biology 76:939–953.
  • Lyon SB, Bounocore L, Miller M. 1987. Naturally occurring methylation inhibitor: DNA hypo-methylation and hemoglobin synthesis in human K562 cells. Molecular and Cellular Biology 7:1759–1763.
  • Marks PA, Rifkind RA, Richon VM, Breslow R. 2001. Histone deacetylases and cancer: Causes and therapies. Nature Reviews Cancer 1:194–202.
  • Mary TS, Catharine MLW. 2001. Ability to undergo apoptosis does not correlate with the intrinsic radiosensitivity (SF2) of human cervix tumor cell lines. International Journal of Radiation Oncology Biology and Physics 50:503–509.
  • Mitsuru N, Kazuhiro D, Sachiko I, Shin IT, Teruo A. 2006. Low-dose radiation response of the p21WAF1/CIP1 gene promoter transduced by adeno-associated virus vector. Experimental and Molecular Medicine 38:553–564.
  • Pogribny I, Raiche J, Slovack M, Kovalchuk O. 2004a. Dose-dependence, sex and tissue-specificity and persistence of radiation-induced genomic DNA methylation changes. Biochemical and Biophysical Research Communications 320:1253–1261.
  • Pogribny IP, James SJ, Jernigan S, Pogribna M. 2004b. Genomic hypomethylation is specific for preneoplastic liver in folate/methyl deficient rats and does not occur in non-target tissues. Mutation Research 548:53–59.
  • Raaphorst GP, Boyden S. 1999. Adaptive response and its variation in human normal and tumor cells. International Journal of Radiation Biology 75:865–873.
  • Raiche J, Rodriguez JR, Pogribny I, Kovalchuk O. 2004. Sex and tissue specific expression of maintenance and de novo DNA methyltransferases upon low dose X-irradiation in mice. Biochemical and Biophysical Research Communications 325:39–47.
  • Raju U, Gumin GJ, Tofilon PJ. 2002. Radiation induced transcription factor activation in the rat cerebral cortex. International Journal of Radiation Biology 78:643–658.
  • Razin A, Cedar H. 1994. DNA methylation and genomic imprinting. Cell 77:473–476.
  • Razin A, Kafri T. 1994. DNA methylation from embryo to adult. Nucleic Acid Research 48:53–81.
  • Robertson KD. 2002. DNA methylation and chromatin-unraveling the tangled web. Oncogene 21:5361–5379.
  • Rosato RR, Grant S. 2005. Histone deacetylase inhibitors: Insights into mechanisms of lethality. Expert Opinion on Therapeutic Targets 9:808–809.
  • Rountree MR, Bachman KE, Herman JG, Baylin SB. 2001. DNA methylation, chromatin inheritance and cancer. Oncogene 20: 3156–3165.
  • Sambrook J, Maniatis T, Fritsch EF. 1992. Molecular cloning: A laboratory handbook. 3rd. New York: Cold Spring Harbor Laboratory.
  • Stapper NJ, Stuschke M, Sak A, Stuben G. 1995. Radiation-induced apoptosis in human sarcoma and glioma cell lines. International Journal of Cancer 62:58–62.
  • Steven JD, Jung G, Walter J, Curran JR, George I. 1999. Repair of DNA double strand-breaks and radiosensitivity to killing in an isogenic group of P53 mutant cell lines. International Journal of Radiation Oncology Biology and Physics 45:743–751.
  • Su LN, Little JB. 1993. Prolonged cell cycle delay in radioresistant human cell lines transfected with activated ras oncogenes and/or simian virus 40T-antigen. Radiation Research 133:73–79.
  • Tawa R, Kimura Y, Komura J. 1998. Effects of X-ray irradiation on genomic DNA methylation levels in mouse tissues. Journal of Radiation Research 39:271–278.
  • Wan JK, Quynh NV, Meena S, Tamara AL, Kevin DB. 2002. Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line. Oncogene 21: 3864–3871.
  • Wilson VL, Jones PA. 1983. Inhibition of DNA methylation by chemical carcinogens in vitro. Cell 32:239–246.
  • Xu WS, Parmigiani RB, Marks PA. 2007. Histone deacetylase inhibitors: Molecular mechanisms of action mechanisms of histone deacetylase inhibitors. Oncogene 26:5541–5552.
  • Zhang Y, Jung M, Dritschilo A, Jung M. 2004. Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors. Radiation Research 161:667–674.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.